SHENZHEN TAILI BIOTECHNOLOGY CO LTD

China

Overview

SHENZHEN TAILI BIOTECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering ALFACELL; ALFAMEDX; HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL EXOSOMES; HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS.

API / Drug Master Files

SHENZHEN TAILI BIOTECHNOLOGY CO LTD holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLSActive2026-03-13
  • ALFAMEDXActive2025-11-24
  • HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL EXOSOMESActive2024-08-09
  • ALFACELLActive2023-04-10

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHENZHEN TAILI BIOTECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

11 Battalion Medical Technology Co., Ltd
China
3D Medicines Inc.
China
3r Environmental Technology Co., Ltd
China
4u Health Co., Ltd
China
5 Plus (ningbo) Healthcare And Technology Co., Ltd.
China
A & D Electronics (shenzhen) Co., Ltd.
China
A-gen Biotech
China
A-one Medical Supplies
China

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo